CDEK
← All organizations

Mayne Pharma

For profitContributed to NME

Also known as: Halcygen Pharmaceuticals Limited | MAYNE PHARMA | MAYNE PHARMA COMMRCL | MAYNE PHARMA INC | Mayne Pharma International Pty Ltd | MAYNE PHARMA INTL

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 1, 2008

First marketed drug

Jan 26, 1981

First NDA

Apr 15, 2021

Last known activity

May 15, 2021

Timeline

1840s

  1. Jan 1, 1845

    Mayne Pharma— Founded

2000s

  1. Jul 1, 2005

    PH&T S.p.A.— Acquired

2010s

  1. Jan 1, 2012

    Metrics, Inc— Acquired

  2. Apr 8, 2016

    budesonide— Marketing Organization

  3. Aug 10, 2018

    ethinyl estradiol— NDA Secondary Org

2020s

  1. Apr 15, 2021

    estetrol— NDA Organization

Drugs by trial phase (9 distinct, 12 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (2 own, 1 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (62)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (12)

Details

Founded
Adelaide, AU Jan 1, 1845
First NDA
Apr 15, 2021
Last known activity
May 15, 2021